AzTrials
AzTrials

Chronic Kidney DiseaseNCT03049527

CKDu in Sugarcane Workers in Guatemala

A study testing Education, Incentives and Feedback in people with Chronic Kidney Disease, run by University of Colorado, Denver at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this research project is to investigate specific behaviors and exposures related to sugarcane work and their association with non-communicable diseases, specifically Chronic Kidney Disease of Unknown Origin (CKDu) among sugarcane workers in Guatemala. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Chronic Kidney Disease
What is being tested?
Education, Incentives and Feedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
531 participants
Where
2 sitesin 2 countries
Study dates
1 Feb 2017to 27 Apr 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • currently employed by Pantaleon
  • age 18 or older.

Who cannot join

  • pregnant women

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • University of Colorado Anschutz Medical Campus

    Aurora, Colorado, 80045

Other trials in United States

Guatemala1 site
  • Panteleon

    Escuintla

Other trials in Guatemala

About this study

Official title: Understanding Occupational and Non-occupational Risks Associated With CKDu in Sugarcane Workers in Guatemala

The objective of this research project is to investigate specific behaviors and exposures related to sugarcane work and their association with non-communicable diseases, specifically Chronic Kidney Disease of Unknown Origin (CKDu) among sugarcane workers in Guatemala. Over the course of the 6-month sugarcane harvest the investigators will assess risk factors for declining kidney function, and also changes in biomarkers of kidney function pre and post work shift of field and factory workers and their possible relationships with dehydration and heat stress. The investigators will also evaluate the effectiveness of an intervention aimed at increasing hydration and reducing heat stress. Finally the investigators will measure biomarkers of exposure and environmental samples for heavy metals, agrochemicals, and infectious disease (Leptospira).

Read the detailed description

This protocol describes two prospective cohort studies and one intervention study that will be conducted throughout the sugarcane harvest, from October through May, at Pantaleon's sugarcane plantations in Guatemala.

Overview of Studies

The investigators propose to conduct the three studies by making use of existing pre-employment data from prior years and by collecting new data during the 6-month sugarcane harvest. Pre-employment data are collected for all workers (N=5000) by Pantaleon and screenings occur throughout the harvest. Pre-employment and screening data include information on demographics, behaviors, work practices, non-communicable diseases, including kidney disease.

The purpose of the three new studies will be to collect detailed data on risk factors and biomarkers for CKDu. Risk factors will be assessed by collecting information through surveys and medical exams, and by collecting biological samples (blood and urine) from a subsample of the workers.

Study 1) Natural History of CKDu Study

Study Rationale: This study will prospectively follow a cohort of sugarcane workers (N=407) over multiple years to understand the natural history of CKDu. By following this cohort of workers, we will be able to describe the prevalence and incidence of abnormal eGFR and identify risk factors for CKDu.

Study Design and Populations: Pantaleon conducted a post-harvest evaluation of 407 workers following the 2015-2016 harvest. The investigators will conduct a prospective longitudinal study of this established cohort of workers (recruited during the end of the 2015-16 harvest) and will work with Pantaleon to replicate this post-harvest evaluation at the end of the 2016-2017 harvest.

Study 2) Industrial Mill Worker Observational Study

Study Rationale: This study will prospectively follow a stratified random selection of 100 mill workers throughout the harvest to understand the prevalence and incidence of kidney damage. The investigators will be able to describe the prevalence and incidence of abnormal eGFR and identify risk factors for CKDu. Although mill workers are indoors, we have informally observed that some of them work under conditions of high heat, placing them at risk for heat stress, dehydration and possibly CKDu.

Study Design and Population: Occupational Health and Safety staff at Pantaleon have identified job descriptions associated with heat exposure in the mill. Pantaleon will conduct pre-employment evaluations among 100 mill workers, specifically selecting a random sample of workers with job titles associated with high heat. At the end of the harvest, the investigators will collect occupational and non-occupational risk factors through a survey and medical exam and measure creatinine levels through a blood finger prick among the 100 mill workers.

Study 3) Hydration Study

Study Rationale: This study will prospectively assess acute and chronic kidney damage among sugarcane workers by evaluating kidney function a) before the start of the harvest and at the end of the harvest, and b) before and after work shifts during the harvest. An intervention will be implemented aimed at increasing hydration and reducing heat stress among sugarcane workers throughout the day. The investigators will assess the effectiveness of this intervention in increasing hydration and work productivity, with the final goal of the intervention aimed at decreasing acute and chronic kidney damage.

Study Design and Population: This study will comprise of the following: 1) implementation of an intervention which will include a wellness incentive and enhanced education on heat stress and hydration, and 2) investigation of biological markers of dehydration and acute kidney injury among approximately 500 sugarcane workers. Workers will be recruited from 10 work groups randomly selected at the Pantaleon work site. Each group will have data collected 3 times during the 6-month harvest.

Sub-Study 3.1) Heat Sub-study

Study Rational: This sub-study will increase understanding of the physiological response of workers to heat exposure and determine the workers' metabolic workload. The investigators will be able to examine across shift changes of physiological responses and its effects on acute and chronic kidney function. It will help determine if workers are receiving sufficient duration and number of rest periods.

Study Design and Population: Among the participants of the Hydration study, 100 workers will be randomly selected to participate in the Heat study. Data for this study will be collected during 3 periods of the Hydration Study (November, January, and March). When each Heat Sub-study participant is having data collected for the Hydration Study, the investigators will collect this additional information for that participant.

Being tested
Education, Incentives and Feedback
Keywords
Chronic Kidney Disease, Unknown Origin
Medical subject headings
Renal Insufficiency, Chronic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Education, Incentives and FeedbackBehavioural

    The study participants will receive additional educational activities, including low-literacy fact sheets on liquid intake guidelines, cards with instructions on how to self-monitor urine color and volume, and flyers and posters placed throughout the worksite. All consenting study participants will be offered incentives to start the work day hydrated and then to maintain or improve their hydration status over the work shift. Participants who do not meet hydration goals will receive additional coaching and feedback on ways to improve hydration.Feedback will also be provided to all groups about their productivity level to help participants recognize the connection between improved health and function.

Study groups in NCT03049527
Study groupRoleWhat they receive
Education, Incentives and FeedbackExperimentalEducation, Incentives and Feedback are all directed to all study participants.
Receives: Behavioral: Education, Incentives and Feedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in Abnormal Glomerular Filtration Rate (eGFR)

    Calculated from serum creatinine levels measured in blood samples. Abnormal eGFR is defined as an eGFR of <60 ml/min/1.73 m2. Serum creatinine will be used to calculate eGFR using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation for all participants. Lower eGFR and higher serum creatinine levels indicate worse kidney function.

    Measured: Day 0 then every 4 weeks for 8 weeks

Secondary outcomes (2)
  1. Change in Prevalence of Workplace Injuries and Illnesses

    Self-reported injuries and illness will be collected via the surveys, which we will use to compare with data collected in the field by Pantaleon's health auxiliary nurses. All data collected will be de-identified as described in detail below. In addition, the incidence of non-communicable diseases will be examined in the Pantaleon study such as diabetes, hypertension, and obesity. Participants will be classified as having diabetes or hypertension if they reported a history of or were currently treated for diabetes or hypertension. Participants will be classified as obese if their body mass index was ≥30 kg/m2 (based on World Health Organization classifications). In addition, incidence of symptoms indicative of the infectious disease Leptospirosis will be collected.

    Measured: Week 1 and 6 months

  2. Change in Productivity

    Reported from Pantaleon's daily records of tons of cane produced per worker.

    Measured: Over the 6 month harvest period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2017
  2. Study start1 Feb 2017
  3. Primary completion27 Apr 2017
  4. Study completion27 Apr 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Screening
Allocation
Not applicable
Intervention model
Single group
Model description
The single group will receive an intervention of enhanced education and incentives aimed at increasing hydration and reducing heat stress.
Masking
None (open label)
Enrolment
531 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03049527
Sponsor's protocol ID
16-1824
Status last verified
Jun 2021
First submitted
31 Jan 2017
Last updated
23 Jun 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Education, Incentives and Feedback in people with Chronic Kidney Disease, run by University of Colorado, Denver at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Guatemala. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in Abnormal Glomerular Filtration Rate (eGFR) (time frame: Day 0 then every 4 weeks for 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in